Skip to main content
. 2022 Feb 21;45(4):1631–1650. doi: 10.1007/s10753-022-01647-8

Table 2.

Demographic Summary of the Control Subjects

Controls for CD cohort 1 and UC cohort (tissue) Controls for CD cohort 2 (tissue) Controls for CD cohort 2 (serum/PBMCs)
Number of subjects 17 13 19
Male/female/ND 7/9/1 7/6/0 8/8/3
Age1 66 (22–94) 75 (61–86) 38 (25–74)
Examination (endoscopy2/surgery3) 5/12 0/13 NA4
Type of sample (tissue/blood5) 17/0 13/0 0/19

Tissue collected

(ileum/ileum and colon/colon)

7/1/9 13/0/0 NA
Samples prepared from blood (serum6/PBMCs) NA NA 8/11

1Data are shown as median (range)

2Individuals undergoing endoscopy for health screening

3CRC patients undergoing surgery where macroscopically normal tissue at least 10 cm from the tumor was taken

4NA, not applicable

5Blood donors

6Serum was from age- and sex-matched blood donors